BioXcel Therapeutics, Inc. Receivables, Net, Current
BioXcel Therapeutics, Inc. (BTAI) had Receivables, Net, Current of $82.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:ReceivablesNetCurrent · last filed 2026-08-13
- 2026-06-30: Receivables, Net, Current $82.00K.
- 2026-03-31: Receivables, Net, Current $216.00K.
- 2025-12-31: Receivables, Net, Current $233.00K.
- 2025-09-30: Receivables, Net, Current $0.00.
| Period end | Receivables, Net, Current |
|---|---|
| 2026-06-30 | $82.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $216.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $233.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 |
| 2025-06-30 | $17.00K 10-Q · filed 2025-08-12 |
| 2024-12-31 | $131.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $3.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $812.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $378.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $71.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $735.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $431.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $283.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $248.00K 10-K · filed 2024-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |